Leadership >
A Pattern of Pre-emptive Disruption:
You can tell a lot about a company by the people who lead it — their skills, their stories and their standards. Our business is foundational technology. Our leaders are the foundation we build on.
Richard Vellacott
BSc Hons ACACEO
Interim CEO, Deputy CEO, CFO and COO of Horizon Discovery Group plc since 2012, building the global leader in gene editing, including 4 acquisitions and one of the most successful ever Life Science IPOs on AIM. Previously Vice President, Finance at the FTSE250 dual listed semiconductor business CSR plc.
Dr Colin Barker PhD FCMI
CSO
20+ years development of biological products and services including regulated standards, diagnostics and automation. Previously at Horizon Discovery Group plc and the Animal Health Trust.
Nick Rollings
CEng MIMechE
CTO
20+ years in Cambridge-based technology consultancies. Experienced in manufacturing engineering, mechanical engineering and systems design. Development and commercialisation of platform technologies for life sciences.